SCHEDULE 13D/A

ImmunityBio Inc

Common Stock, par value $0.0001 per share · CUSIP: 45256X103

Event date: 2026-02-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Cambridge Equities, LPReported CIK 0001629222

  Shares: 261,705,814 · Class: 25.5%

• MP 13 Ventures, LLCReported CIK 0001629186

  Shares: 261,705,814.00 · Class: 25.5%

• NantWorks, LLCReported CIK 0001675760

  Shares: 98,535,253.00 · Class: 9.6%

• Nant Capital, LLCReported CIK 0001675758

  Shares: 339,465,529.00 · Class: 30.3%

• California Capital Equity, LLCReported CIK 0001517764

  Shares: 106,511,412.00 · Class: 10.4%

• Patrick Soon-ShiongReported CIK 0001189020

  Shares: 745,576,456.00 · Class: 66.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.